These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 35443672)

  • 1. Patients admitted to treatment for substance use disorder in Norway: a population-based case-control study of socio-demographic correlates and comparative analyses across substance use disorders.
    Amundsen EJ; Bretteville-Jensen AL; Rossow I
    BMC Public Health; 2022 Apr; 22(1):792. PubMed ID: 35443672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medical Costs of Substance Use Disorders in the US Employer-Sponsored Insurance Population.
    Li M; Peterson C; Xu L; Mikosz CA; Luo F
    JAMA Netw Open; 2023 Jan; 6(1):e2252378. PubMed ID: 36692881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Demographic trends associated with substance use disorder and risk for adverse obstetric outcomes with cannabis and opioid use disorders.
    Logue TC; Wen T; Friedman AM
    J Matern Fetal Neonatal Med; 2022 Dec; 35(26):2128658. PubMed ID: 36617462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polysubstance use and association with opioid use disorder treatment in the US Veterans Health Administration.
    Lin LA; Bohnert ASB; Blow FC; Gordon AJ; Ignacio RV; Kim HM; Ilgen MA
    Addiction; 2021 Jan; 116(1):96-104. PubMed ID: 32428386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and correlates of alcohol and other substance use disorders in young adulthood: A population-based study.
    Latvala A; Tuulio-Henriksson A; Perälä J; Saarni SI; Aalto-Setälä T; Aro H; Korhonen T; Koskinen S; Lönnqvist J; Kaprio J; Suvisaari J
    BMC Psychiatry; 2009 Nov; 9():73. PubMed ID: 19925643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence, patterns, and correlates of multiple substance use disorders among adult primary care patients.
    John WS; Zhu H; Mannelli P; Schwartz RP; Subramaniam GA; Wu LT
    Drug Alcohol Depend; 2018 Jun; 187():79-87. PubMed ID: 29635217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Religious institutions as a link to substance use treatment: Characterizing the potential service population through national survey data.
    Heikkila HD; Edens EL; Stefanovics EA; Rhee TG; Rosenheck RA
    Subst Abus; 2022; 43(1):699-707. PubMed ID: 35099366
    [No Abstract]   [Full Text] [Related]  

  • 8. Cross-national patterns of substance use disorder treatment and associations with mental disorder comorbidity in the WHO World Mental Health Surveys.
    Harris MG; Bharat C; Glantz MD; Sampson NA; Al-Hamzawi A; Alonso J; Bruffaerts R; Caldas de Almeida JM; Cia AH; de Girolamo G; Florescu S; Gureje O; Haro JM; Hinkov H; Karam EG; Karam G; Lee S; Lépine JP; Levinson D; Makanjuola V; McGrath J; Mneimneh Z; Navarro-Mateu F; Piazza M; Posada-Villa J; Rapsey C; Tachimori H; Ten Have M; Torres Y; Viana MC; Chatterji S; Zaslavsky AM; Kessler RC; Degenhardt L;
    Addiction; 2019 Aug; 114(8):1446-1459. PubMed ID: 30835879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prevalence of substance use disorders among people in Norwegian, Danish and Swedish prisons: A multi-national cohort study, 2010-19.
    Bukten A; Virtanen S; Hesse M; Thylstrup B; Kvamme TL; Seid AK; Chang Z; Skjærvø I; Tverborgvik T; Stavseth MR
    Addiction; 2024 Jul; 119(7):1264-1275. PubMed ID: 38529890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistence/recurrence of and remission from DSM-5 substance use disorders in the United States: Substance-specific and substance-aggregated correlates.
    McCabe SE; West BT; Strobbe S; Boyd CJ
    J Subst Abuse Treat; 2018 Oct; 93():38-48. PubMed ID: 30126540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adult attention-deficit/hyperactivity disorder and its association with substance use and substance use disorders in young men.
    Estévez N; Dey M; Eich-Höchli D; Foster S; Gmel G; Mohler-Kuo M
    Epidemiol Psychiatr Sci; 2016 Jun; 25(3):255-66. PubMed ID: 25989844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical prevalence and correlates of substance use in adolescent psychiatric emergency patients.
    McDonell MG; Hsiao RC; Russo J; Pasic J; Ries RK
    Pediatr Emerg Care; 2011 May; 27(5):384-9. PubMed ID: 21494164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substance use disorders and COVID-19: An analysis of nation-wide Veterans Health Administration electronic health records.
    Hasin DS; Fink DS; Olfson M; Saxon AJ; Malte C; Keyes KM; Gradus JL; Cerdá M; Maynard CC; Keyhani S; Martins SS; Livne O; Mannes ZL; Sherman SE; Wall MM
    Drug Alcohol Depend; 2022 May; 234():109383. PubMed ID: 35279457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cigarette use is increasing among people with illicit substance use disorders in the United States, 2002-14: emerging disparities in vulnerable populations.
    Weinberger AH; Gbedemah M; Wall MM; Hasin DS; Zvolensky MJ; Goodwin RD
    Addiction; 2018 Apr; 113(4):719-728. PubMed ID: 29265574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utilization of addiction treatment among U.S. adults with history of incarceration and substance use disorders.
    Tsai J; Gu X
    Addict Sci Clin Pract; 2019 Mar; 14(1):9. PubMed ID: 30836991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substance use disorders comorbid with mood and anxiety disorders in the Australian general population.
    Prior K; Mills K; Ross J; Teesson M
    Drug Alcohol Rev; 2017 May; 36(3):317-324. PubMed ID: 27324816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substance use disorders and the risk of suicide mortality among men and women in the US Veterans Health Administration.
    Bohnert KM; Ilgen MA; Louzon S; McCarthy JF; Katz IR
    Addiction; 2017 Jul; 112(7):1193-1201. PubMed ID: 28301070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DSM-5 substance use disorders among adult primary care patients: Results from a multisite study.
    Wu LT; McNeely J; Subramaniam GA; Brady KT; Sharma G; VanVeldhuisen P; Zhu H; Schwartz RP
    Drug Alcohol Depend; 2017 Oct; 179():42-46. PubMed ID: 28753480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prevalence and clinical correlates of substance use disorders in patients with psychotic disorders from an Upper-Middle-Income Country.
    Temmingh HS; Mall S; Howells FM; Sibeko G; Stein DJ
    S Afr J Psychiatr; 2020; 26():1473. PubMed ID: 32832129
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.